Decision Diagnostics Corp (DECN)

[nonsequetor]

GenUltimate In Korea


http://www.sisamediin.com/news/articleView.html?idxno=17014

The following is a translation:

Home> News in> Palm
International drugs, blood sugar strips through subsidiaries
Contracted domestic supply of FDA approved strip with KJCare
Material reporter | [e-mail]
Print this article Send this article to a friend

Approval 2017.01.31 18:25:31


The Korea International Trade Association (KINTEX) announced on December 31 that it has entered into a supply contract to import the blood sugar strip 'GenUltimate Test Strips', which has been approved by the US FDA, in Korea.

This supply contract was signed with UnicaCare, a US agent of PharmaTech Soultions, a US FDA licensed person.

The blood strip strip, which is supposed to be supplied exclusively, can be used in conjunction with a blood glucose measuring device using the One Touch Ultra strip to quantitatively measure blood sugar in whole blood, and to obtain fast and accurate results with only a small blood sample of 1.0 µl .

It is constructed at a reasonable price so that consumers can feel free to test it as needed.

In particular, this blood strip strip can be guaranteed to be safe and reliable by producing appropriately according to the manufacturing and quality control guidelines required by the US FDA even after receiving US FDA approval.

With the signing of the supply agreement, International Pharmaceuticals expects to increase the market share of blood glucose strips in Korea by 50 billion won and contribute to sales and profits thanks to the blood glucose strip market, which grows at an annual average rate of more than 5%.

In 2011, KOGAS established KJ Care, a subsidiary that handles medical devices and welfare equipment, in addition to pharmaceuticals.
<Copyright by © Sisa Medi in reprint and redistribution prohibited>
View other articles by material reporter